靶向IL-1介导的炎症能否改善新生儿缺氧缺血性脑病预后?
本文探讨新生儿缺氧缺血性脑病(HIE)的炎症机制,重点分析IL-1介导的炎症在HIE病程中的作用。文章梳理HIE的原发期、潜伏期、继发期和持续数周至数月的第三期,指出慢性神经炎症由持续的小胶质细胞和星形胶质细胞活化驱动并释放IL-1等细胞因子。
要点
- HIE在高资源地区活产儿中发病率约为1–3/1000。
- HIE幸存者可出现脑瘫、癫痫及智力低下等长期损害。
- 慢性神经炎症由持续胶质细胞活化释放IL-1等细胞因子驱动。
核心结论
- HIE病程涉及代谢、兴奋毒性和炎症级联反应,慢性神经炎症由持续小胶质细胞和星形胶质细胞活化释放IL-1等细胞因子驱动。
研究设计与样本
- 本文为针对新生儿HIE中IL-1介导炎症机制的综述性论述。
主要发现
- HIE在高资源地区活产儿中发病率为1–3/1000。
- HIE幸存者常出现脑瘫、癫痫以及边缘至极低IQ等长期损害。
- HIE原发期以ATP耗竭、氧化应激和兴奋毒性导致神经元死亡为特征。
- 潜伏期为6–12小时,存在短暂代谢恢复,提供治疗窗口。
- 继发期以线粒体功能障碍、凋亡和炎症为特征,第三期可持续数周至数月,表现为慢性神经炎症、胶质增生和修复受损。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction Neonatal hypoxic-ischaemic encephalopathy (HIE) caused by inadequate oxygenation and cerebral blood flow at birth has an incidence rate of 1–3 per 1000 live births in high-resource settings. Survivors of HIE frequently experience long-term impairments, including cerebral palsy, epilepsy and borderline to extremely low IQ even in the absence of cerebral palsy. 1 Pathogenesis HIE pathogenesis involves a cascade of metabolic, excitotoxic and inflammatory processes. 1 The primary phase begins with ATP depletion, oxidative stress and excitotoxicity leading to neuronal death. This is followed by a latent phase (6–12 hours) of transient metabolic recovery providing a therapeutic window. Without intervention, a secondary phase ensues, characterised by mitochondrial dysfunction, apoptosis and inflammation. A tertiary phase may persist for weeks to months, marked by chronic neuroinflammation, gliosis and impaired repair. 1 Chronic neuroinflammation is driven by persistent microglial and astrocytic activation, releasing cytokines such as interleukin-1 (IL-1),...
引用
- ADC Fetal and Neonatal:Can targeting IL-1 mediated inflammation improve outcomes after neonatal hypoxic-ischaemic encephalopathy?
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。